Search

everythinglearnresearchcommunity

for

Search:↓

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Most people with scarring and nonscarring hair loss show similar D2-40 levels, but some with scarring hair loss have higher levels.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Too much Smad7 changes skin and hair development by breaking down a protein called β-catenin, leading to more oil glands and fewer hair follicles.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

The document concludes that the trichogram is a useful tool for diagnosing hair loss and suggests semi-organ cultures for practical trichological research.

The circadian clock in skin cells controls their growth and rest cycles.

Topical spironolactone effectively treats hair loss in women.

Removing the ATR gene in adult mice causes rapid aging and stem cell loss.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The Apc gene is crucial for normal skin and thymus development.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Smad-4 and Smad-7 are key in hair follicle development, with other Smads being less important.

The extracellular matrix is crucial for controlling skin stem cell behavior and health.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.